Restless Legs Syndrome is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Restless Legs Syndrome (RLS), also known as Willis-Ekbom Disease, is a neurological disorder characterized by an irresistible urge to move the legs, often accompanied by uncomfortable sensations. These symptoms typically worsen during periods of rest or inactivity, particularly in the evening and at night, leading to significant sleep disruption and impaired quality of life[^1]. [^2]
RLS is classified as a sensorimotor disorder and is thought to involve dysfunction in the dopaminergic pathways of the central nervous system, particularly the basal ganglia and nigrostriatal system — pathways also implicated in neurodegenerative diseases like Parkinson's disease[^2]. [^3]
Pathophysiology
The exact mechanisms underlying RLS remain incompletely understood, but several key factors have been identified: [^4]
Dopaminergic Dysfunction
Impaired dopaminergic neurotransmission in the brain, particularly in the A11 hypothalamic dopaminergic pathway
Reduced iron availability in the brain, which is essential for dopamine synthesis
Dysregulation of D2 receptors in the striatum
...
Restless Legs Syndrome
Introduction
Restless Legs Syndrome is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Restless Legs Syndrome (RLS), also known as Willis-Ekbom Disease, is a neurological disorder characterized by an irresistible urge to move the legs, often accompanied by uncomfortable sensations. These symptoms typically worsen during periods of rest or inactivity, particularly in the evening and at night, leading to significant sleep disruption and impaired quality of life[^1]. [^2]
RLS is classified as a sensorimotor disorder and is thought to involve dysfunction in the dopaminergic pathways of the central nervous system, particularly the basal ganglia and nigrostriatal system — pathways also implicated in neurodegenerative diseases like Parkinson's disease[^2]. [^3]
Pathophysiology
The exact mechanisms underlying RLS remain incompletely understood, but several key factors have been identified: [^4]
Dopaminergic Dysfunction
Impaired dopaminergic neurotransmission in the brain, particularly in the A11 hypothalamic dopaminergic pathway
Reduced iron availability in the brain, which is essential for dopamine synthesis
Dysregulation of D2 receptors in the striatum
Iron Deficiency
Low iron stores (ferritin) are strongly associated with RLS severity
Iron is a cofactor for tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis
Brain iron deficiency may be present even when systemic iron levels appear normal
Genetic Factors
Familial aggregation is common, with autosomal dominant inheritance patterns in many cases
Several genetic loci have been associated with increased RLS risk
BTBD9, MEIS1, MAP2K5, and LBXCOR1 are among the identified susceptibility genes
Central Nervous System Involvement
Abnormalities in sensory processing in the spinal cord and brain
Altered sensorimotor integration
Possible involvement of the opioid system
Symptoms
Primary Symptoms
Urge to Move Legs: An overwhelming need to move the legs, often described as an irresistible compulsion
Uncomfortable Sensations: Described as crawling, itching, tingling, pulling, creeping, electric, or painful sensations
Worsening at Rest: Symptoms typically begin or worsen during periods of sitting or lying down
Evening Predominance: Symptoms are usually worse in the evening and night hours
Relief with Movement: Symptoms are partially or completely relieved by moving, walking, or stretching
Associated Features
Sleep disturbance: Difficulty falling asleep or staying asleep due to leg discomfort
Periodic limb movements: Involuntary leg movements during sleep (PLMS) in up to 80% of patients
Daytime fatigue: Resulting from sleep disruption
Mood changes: Depression and anxiety are common comorbidities
Diagnosis
Diagnostic Criteria (2014 IRLSSG Consensus)
The diagnosis of RLS is clinical, based on the following essential criteria: [^5]
Urge to move the legs usually accompanied by uncomfortable sensations
Symptoms begin or worsen during periods of rest or inactivity
Partial or complete relief by movement
Symptoms worse in the evening or night
Supportive Clinical Features
Positive family history
Response to dopaminergic therapy
Periodic limb movements during sleep
Diagnostic Workup
Sleep study (polysomnography): To detect periodic limb movements and assess sleep architecture
Iron studies: Serum ferritin, transferrin, iron saturation
Neurological examination: To rule out peripheral neuropathy
[Periodic Limb Movement Disorder](/entities/periodic-limb-movements)
External Links
[National Institute of Neurological Disorders and Stroke - RLS](https://www.ninds.nih.gov/health-information/disorders/restless-legs-syndrome)
[Restless Legs Syndrome Foundation](https://www.rls.org)
[Sleep Foundation - RLS](https://www.sleepfoundation.org/restless-legs-syndrome)
Background
The study of Restless Legs Syndrome has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Recent Research (2024-2026)
This section highlights recent publications relevant to this disease.
[SOMAS - an open-source software for the analysis of muscle activity during sleep.](https://pubmed.ncbi.nlm.nih.gov/41666815/) (2026 May) - Sleep medicine
[Modulation of spinal and cortical neuronal excitability by transcutaneous spinal direct current stimulation in restless legs syndrome.](https://pubmed.ncbi.nlm.nih.gov/41616577/) (2026 Apr) - Sleep medicine
[Efficacy and safety of tonic motor activation (TOMAC) for restless legs syndrome as adjunctive and monotherapy: An individual participant data systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/41581285/) (2026 Apr) - Sleep medicine
[Restless legs syndrome and sleep quality in patients with multiple sclerosis: A moderated mediation model of anxiety, fatigue, and disease duration.](https://pubmed.ncbi.nlm.nih.gov/41564799/) (2026 Apr) - Sleep medicine
[Sleep Health in the Older Adults: Architecture, Circadian Changes, and Common Sleep Disorders.](https://pubmed.ncbi.nlm.nih.gov/41825783/) (2026 Mar 11) - Ageing research reviews